Jason V Baker Selected Research

Viremia

8/2013

Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason V Baker Research Topics

Disease

26	Inflammation (Inflammations) 01/2021 - 08/2008
17	Acquired Immunodeficiency Syndrome (AIDS) 10/2020 - 04/2008
16	HIV Infections (HIV Infection) 01/2020 - 05/2009
13	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 05/2009
6	Infections 01/2022 - 04/2007
5	COVID-19 01/2022 - 01/2020
3	Fibrosis (Cirrhosis) 01/2021 - 06/2011
3	Hypertension (High Blood Pressure) 01/2020 - 10/2011
3	Hepatitis C 10/2014 - 09/2009
3	Hepatitis B 07/2014 - 11/2006
3	Coinfection 07/2014 - 08/2013
3	Neoplasms (Cancer) 01/2014 - 04/2008
3	Liver Diseases (Liver Disease) 01/2014 - 04/2008
2	Pain (Aches) 06/2022 - 03/2022
2	Noncommunicable Diseases 10/2020 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2017 - 08/2013
2	Diabetes Mellitus 05/2017 - 01/2014
2	Atherosclerosis 01/2017 - 06/2010
2	Obesity 10/2015 - 10/2014
2	Substance-Related Disorders (Drug Abuse) 10/2014 - 08/2013
2	Thrombosis (Thrombus) 11/2010 - 04/2007
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Emphysema 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Necrosis 10/2020
1	Hemorrhage 02/2020
1	Hypoalbuminemia 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2017
1	Vitamin D Deficiency 01/2017
1	Vascular System Injuries 01/2017
1	Apnea 11/2015
1	Snoring 11/2015
1	Disorders of Excessive Somnolence (Hypersomnia) 11/2015
1	Insulin Resistance 10/2015
1	Hepatitis 01/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Vascular Diseases (Vascular Disease) 11/2013
1	Alcoholism (Alcohol Abuse) 08/2013
1	Alcohol-Related Disorders 08/2013
1	Viremia 08/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2013
1	Thrombocytopenia (Thrombopenia) 01/2013
1	Bacterial Pneumonia 01/2013

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2010
12	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2010
12	C-Reactive ProteinIBA 01/2020 - 06/2010
12	RNA (Ribonucleic Acid)IBA 01/2017 - 04/2008
11	fibrin fragment D (D-dimer)IBA 02/2020 - 06/2010
7	Pharmaceutical PreparationsIBA 01/2022 - 09/2009
3	remdesivirIBA 01/2022 - 01/2020
3	LipidsIBA 10/2014 - 11/2011
2	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2021
2	Monoclonal AntibodiesIBA 01/2022 - 11/2021
2	bamlanivimabIBA 01/2022 - 11/2021
2	VaccinesIBA 01/2022 - 04/2021
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2021
2	Serum AlbuminIBA 01/2018 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 07/2017 - 01/2014
2	Lipopolysaccharide ReceptorsIBA 10/2015 - 11/2014
2	CholesterolIBA 01/2014 - 01/2014
2	Hyaluronic Acid (Hyaluronan)IBA 01/2014 - 06/2011
2	LDL CholesterolIBA 01/2014 - 10/2011
2	HDL CholesterolIBA 01/2014 - 09/2009
2	Cystatin CIBA 01/2014 - 06/2010
2	HDL LipoproteinsIBA 11/2011 - 11/2010
2	Lipoproteins (Lipoprotein)IBA 04/2011 - 11/2010
1	AntigensIBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 10/2020
1	Factor Xa InhibitorsIBA 02/2020
1	edoxabanIBA 02/2020
1	Factor Xa (Coagulation Factor Xa)IBA 02/2020
1	Investigational DrugsIBA 01/2020
1	LactoferrinIBA 01/2019
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2019
1	Thrombin FDA Link 10/2018
1	AnticoagulantsIBA 10/2018
1	ImmunosorbentsIBA 01/2017
1	EnzymesIBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	LeptinIBA 10/2015
1	Zidovudine (Retrovir)FDA LinkGeneric 07/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2013
1	Ethanol (Ethyl Alcohol)IBA 08/2013
1	Thromboplastin (Tissue Factor)IBA 07/2013
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2013
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2011

Therapy/Procedure

29	Therapeutics 06/2022 - 11/2006
13	Art Therapy 10/2020 - 05/2009
2	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 04/2008
1	Massage (Zone Therapy) 03/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 03/2022
1	Meditation 03/2022
1	Oral Administration 01/2019
1	Stem Cell Transplantation 11/2017